Cargando…
Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond
Treatment with inotropic agents is one of the most controversial topics in heart failure. Initial enthusiasm, based on strong pathophysiological rationale and apparent empirical efficacy, has been progressively limited by results of controlled trials and registries showing poorer outcomes of the pat...
Autores principales: | Teerlink, John R., Metra, Marco, Zacà, Valerio, Sabbah, Hani N., Cotter, Gadi, Gheorghiade, Mihai, Cas, Livio Dei |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer US
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2772951/ https://www.ncbi.nlm.nih.gov/pubmed/19876734 http://dx.doi.org/10.1007/s10741-009-9153-y |
Ejemplares similares
-
Use of Inotropic Agents in Treatment of Systolic Heart Failure
por: Tariq, Sohaib, et al.
Publicado: (2015) -
Efficacy of the New Inotropic Agent Istaroxime in Acute Heart Failure
por: Forzano, Imma, et al.
Publicado: (2022) -
Comparison of Positive Inotropic Agents in the Management of Acute Decompensated Heart Failure
por: Kelly, Julie, et al.
Publicado: (2020) -
Relaxin: Review of Biology and Potential Role in Treating Heart Failure
por: Teichman, Sam L., et al.
Publicado: (2010) -
Acute heart failure syndromes
por: Gheorghiade, Mihai
Publicado: (2009)